News

Hamacher Resource Group to talk front-end strategy to pharmacy students

BY Michael Johnsen

WAUKESHA, Wis. — Hamacher Resource Group on Wednesday announced it will present a session about pharmacy layout, design and merchandising principles on Sept. 3 to third-year students in the Pharmacy School at Concordia University, in Mequon, Wis. 

Tom Boyer, a 19-year veteran of the retail consumer healthcare industry, national account manager and co-owner at HRG, will present these topics to help students understand the importance and profit potential of the front-end of the pharmacy. Boyer’s presentation includes merchandising guidelines to create a shopping experience that both improves customer satisfaction and boosts front-of-store sales.

“The students can connect their practice/experiential training both behind the counter and in the front-end, to the tools and services that Tom describes in his presentation," suggested Dean Arneson, dean of the Pharmacy School. 

This is Boyer’s second year presenting the importance of front-of-store merchandising to the Concordia pharmacy students. He also has given similar sessions at other pharmacy schools across the country, urging future pharmacists to pay attention to their customers’ needs and design their front end to encourage a pleasant shopping experience.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Costco highlights craft brewers

BY Alaric DeArment

ISSAQUAH, Wash. — Craft brewers are the star of the show in the latest issue of Costco Wholesale’s member magazine.

For the cover story of the September issue of Costco Connection, the club retailer solicited stories from members who had turned brewing as a hobby into businesses, or dreamed of doing so, receiving more than 500 responses.

Breweries profiled include Two Brothers Brewing Co. of Warrenville, Ill.; Copper Kettle Brewing Co, of Denver; Mac & Jack’s Brewery of Redmond, Wash.; and Maui Brewing Co. of Lahaina, Hawaii.

The four profiles provide a snapshot of an industry that has grown rapidly in recent years, as home brewers turn their hobbies into businesses and Americans’ tastes broaden beyond mass-produced, light lagers. According to a recent report by IBISWorld, the number of craft brewers has grown by 10.9% per year since 2008, with 2,439 businesses showing 2013 sales of $3.9 billion and profits of $378 million, and expectations of more than 7% annual growth in the number of enterprises through 2018. American craft beers also have grown in popularity abroad, with $46.9 million in exports in 2013.

The Boston Beer Co., which makes Sam Adams, commands a 19.3% market share, while the Sierra Nevada Brewing Co., based in California, commands 5.1%. Pale ales make up the bulk of craft brews, about 41%, while lagers make up 27.9%, coffee-colored stouts and porters constitute 13%, and seasonal beers constitute 18.1%.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Endo subsidiary to buy Boca Pharmacal for $225 million

BY Alaric DeArment

MALVERN, Pa. – A subsidiary of Endo Health Solutions is buying Boca Pharmacal for $225 million, Endo said Wednesday.

The Malvern, Pa.-based drug maker said the acquisition, through its Qualitest generics subsidiary, would give it access to a "unique" portfolio of generic drugs, an attractive pipeline and would build on Qualitest’s strength in controlled substances. Boca focuses on niche areas, commercializing and developing drugs that include controlled substances, semisolids and solutions.

"The acquisition of Boca Pharmacal is the first of several transactions we expect to execute as we transform Endo into a more focused specialty healthcare company with a lean operating model, able to deliver consistent earnings and revenue growth for our shareholders," Endo CEO Rajiv De Silva said. "The acquisition is aligned with our current generics footprint and will meaningfully accelerate the growth of Qualitest in 2014. I believe that the revenue and earnings contribution of this transaction, combined with the unique commercial portfolio and strong pipeline of ANDAs, make this an ideal fit."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?